Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0V9MV
|
|||
Former ID |
DIB016503
|
|||
Drug Name |
IDDBCP226234
|
|||
Synonyms |
Serine/threonine-protein kinase PIM-2 inhibitor (inflammation), Boehringer Ingelheim
Click to Show/Hide
|
|||
Indication | Inflammation [ICD-11: 1A00-CA43.1] | Investigative | [1] | |
Company |
Boehringer Ingelheim Corp
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Serine/threonine-protein kinase pim-2 (PIM2) | Target Info | Inhibitor | [1] |
KEGG Pathway | Acute myeloid leukemia | |||
NetPath Pathway | IL1 Signaling Pathway | |||
TCR Signaling Pathway | ||||
IL2 Signaling Pathway | ||||
WikiPathways | Hematopoietic Stem Cell Differentiation |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2159). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.